FDA (CDER)
GUIDANCE DRAFT
Forms FDA 3542a and FDA 3542: Questions and Answers
Published: 6/15/2026Detected: 6/12/2026
Summary preview
Questions and Answers draft addressing FDA Forms 3542 and 3542a is intended to clarify how respondents should complete and submit the relevant forms, potentially reducing inconsistencies in regulatory submissions.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountquality
safety
clinical
labeling
manufacturing
#FDA Form 3542
#FDA Form 3542a
#questions and answers
#submission instructions
#regulatory compliance
Official Source Document Source Verified
Access the original document directly from FDA CDER.
More from FDA (CDER)
- E2B(R3) Electronic Transmission of Individual Case Safety Reports Implementation Guide — Data Elements and Message Specification; and Appendix to the Implementation Guide — Backwards and Forwards Compatibility10/1/2026
- Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates: Guidance for Industry9/8/2026
- Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing and Labeling9/2/2026
- Evaluation of Therapeutic Equivalence8/21/2026
- Determining Whether to Submit an ANDA or a 505(b)(2) Application8/17/2026